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Background. Studies estimating excess length of stay (LOS) attributable to nosocomial infections have failed to address 
 time-varying confounding, likely leading to overestimation of their impact. We present a methodology based on inverse proba-
bility–weighted survival curves to address this limitation.
Methods. A case study focusing on intensive care unit–acquired bacteremia using data from 2 general intensive care units 
(ICUs) from 2 London teaching hospitals were used to illustrate the methodology. The area under the curve of a conventional 
Kaplan-Meier curve applied to the observed data was compared with that of an inverse probability–weighted Kaplan-Meier curve 
applied after treating bacteremia as censoring events. Weights were based on the daily probability of acquiring bacteremia. The dif-
ference between the observed average LOS and the average LOS that would be observed if all bacteremia cases could be prevented 
was multiplied by the number of admitted patients to obtain the total excess LOS.
Results. The estimated total number of extra ICU days caused by 666 bacteremia cases was estimated at 2453 (95% confidence 
interval [CI], 1803–3103) days. The excess number of days was overestimated when ignoring time-varying confounding (2845 [95% 
CI, 2276–3415]) or when completely ignoring confounding (2838 [95% CI, 2101–3575]).
Conclusions. ICU-acquired bacteremia was associated with a substantial excess LOS. Wider adoption of inverse probability–
weighted survival curves or alternative techniques that address time-varying confounding could lead to better informed decision 
making around nosocomial infections and other time-dependent exposures.
Keywords.  bacteremia; infection; excess length of stay; causal inference; confounding.
Healthcare-associated infections (HCAIs) represent a public 
health problem and are associated with substantial morbidity, 
mortality, and costs [1–5]. A substantial proportion of HCAIs 
can be prevented by implementing infection prevention and 
control measures [4, 6–9].
While interventions may be effective, it is important to as-
sess whether they are also cost-effective in the context of lim-
ited funds for healthcare. A  key driver of the costs of HCAIs 
and—depending on the economic perspective, reimbursement 
system, and intervention—the cost-effectiveness of interven-
tions targeting HCAI incidence is the excess length of stay 
(LOS) caused by these infections [6, 10]. To obtain useful esti-
mates for policy making, studies need to take into account the 
timing of infection and the fact that patients who acquire an 
infection may not only differ at the day of admission, but also 
may deteriorate more before acquiring infection than patients 
who remain infection-free [11].
Common methodologies to account for the timing of infec-
tion are multistate models and Cox regression with infection 
implemented as a time-varying variable [12–14]. Applications 
of multistate models often do not adjust for baseline con-
founding and never correctly adjust for time-varying con-
founding (eg, severity of illness) [12, 15], which can limit their 
use. Furthermore, hazard ratios obtained from Cox regression 
models are often misinterpreted and do not readily translate 
into excess LOS in days [16, 17].
To address limitations of commonly applied methods, time-
varying confounding can be adjusted for using marginal structural 
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In the presence of measured time-varying confounding, which is 
affected by past exposure, these and other g-methods have been 
shown to provide valid results where more conventional method-
ologies produce biased estimates [19–22].
When a time-varying confounder is also an interme-
diate variable on the causal pathway (eg, severity of illness 
is affected by the history of infection), adjusting for it would 
partly remove the effect of the exposure when using conven-
tional regression techniques; it would moreover introduce 
collider-stratification bias, a form of selection bias that oc-
curs when one controls for a common effect of exposure and 
outcome [11, 15, 23]. This has been empirically confirmed in 
simulation studies, which showed that a marginal structural 
model with IPW resulted in unbiased estimates of the effect 
of time-dependent harmful exposures on the hazard of hos-
pital discharge [20]. In contrast, adjusting for time-varying 
confounding using a conventional Cox regression model 
with time-varying covariates, or freezing the time-varying 
confounder at their level before occurrence of the exposure, 
resulted in substantial bias [20].
Previous studies have not applied methods that cor-
rectly account for potential time-varying confounding when 
estimating excess LOS measured in days [15]. We recently 
used Cox proportional hazards regression to estimate what 
the observed risk of death in and discharge from the intensive 
care unit (ICU) would be if all patients in an ICU would re-
main bacteremia free compared to the actual situation where 
some patient do acquire bacteremia [11]. The corresponding 
survival curves could theoretically be combined to estimate 
the excess LOS. However, when the proportional hazards as-
sumption holds conditional on a set of covariates, then it is 
almost guaranteed not to hold when one covariate is added 
or dropped. It is unlikely that one would have selected the 
precise set of covariates for which the proportional hazards 
assumption holds.
In view of this, we will instead make use of Kaplan-Meier 
(KM) curves along with IPW to predict what the LOS distri-
bution would be if nosocomial infections could be prevented 
[24, 25]. Provided all confounders are measured and included 
in the model to create the inverse probability weights, one can 
assess excess LOS by comparing the observed LOS with that in 
the counterfactual situation, where all patients would remain 
infection-free. A  major advantage of this method compared 
to several other approaches currently applied to estimate the 
excess LOS is that it simultaneously (i) does not suffer from 
bias due to ignoring the timing of infection; (ii) can address 
(measured, time-varying) confounding; (iii) does not require 
a proportional hazards assumption; (iv) has no built-in selec-
tion bias; and (v) produces excess LOS measured in days. We 
show using a case study how excess LOS due to time-dependent 
exposures such as ICU-acquired bacteremia can be estimated 
using KM estimators with IPW.
METHODS
Data
For our case study, we used data from all patients admitted to 
two 15-bed general ICUs at St Thomas’ Hospitals (London, 
United Kingdom) between January 2002 and March 2006 [11, 
18]. Besides daily measurements on various invasive procedures 
and markers of severity of illness, these data contain informa-
tion on admission, discharge, mortality, and administration 
of antimicrobial therapy [11]. Patients with an ICU LOS of < 
3 days were excluded because patients could, by definition, only 
acquire bacteremia after being 2 days in the ICU. From the re-
maining cohort, we excluded patients with a blood culture pos-
itive for bacteria during the first 2 days in the ICU, to exclude 
community-acquired cases. After applying these exclusion cri-
teria, a first blood culture positive for any bacteria obtained 
from the patient > 2 days after ICU admission was considered 
an ICU-acquired bacteremia. In line with other studies [1–3, 
11–14, 18], only first infections were considered. Onset of in-
fection was defined utilizing the time of the specimen taken as 
a proxy for time of infection.
The final model (Supplementary Material 1 for more details 
on all considered confounders and model selection) included 
age (restricted cubic spline with 2 degrees of freedom) and sex 
as baseline covariates and the Acute Physiology and Chronic 
Health Evaluation (APACHE) II score, receipt of any systemic 
antibiotic (yes/no), mechanical ventilation, and central lines as 
time-varying confounders [18]. For the APACHE score and an-
tibiotic use, we used lagged values 2 days before to recognize 
that these variables measured within 24 hours before the onset 
of bacteremia are possible surrogate markers for an infection 
that was incubating and may therefore be affected by bacteremia 
[11, 18, 26]. Besides using these lagged values, we also adjusted 
for the cumulative previous time on mechanical ventilation and 
having received antibiotics (days on treatment). Furthermore, 
an interaction between the cumulative previous time on anti-
biotics and the cumulative previous time having received me-
chanical ventilation and an interaction between the presence of 
central lines on the first day of admission and the time-varying 
1-day lagged presence of central lines were also included in the 
final model (see Supplementary Material 1, including sensitivity 
analyses using different lags).
Analyses
We estimated the effect of bacteremia on LOS using several 
steps. We estimated the survival probabilities up to day 45 in 
the ICU for the observed data using conventional KM method-
ology. Subsequently we summed the survival probabilities for 
each day up to day t = 45 to obtain the average LOS up to day 45. 
This is the restricted mean survival time, which is equivalent to 
the area under the KM curve up to day 45 [27]. It can be inter-
preted as the average survival time within the interval of interest 
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because the effect of bacteremia acquired later during the ICU 
stay may have a more limited impact and adjusting for poten-
tial time-varying confounding is more challenging for late in-
fections, because there are simply insufficient numbers patients 
who acquire infection at the same time. Furthermore, only a 
very small proportion of patients stayed longer than 45 days in 
the ICU (3%), and the predicted probability of staying for at 
least 45 days in the ICU if bacteremia would be prevented was 
even lower (1.9%).
Subsequently, we treated bacteremia as a “censoring” event. 
Because patients who acquire an infection likely differ from 
patients who remain infection-free, a conventional KM curve 
based on these censored event times would be biased. We 
adjusted for this bias using IPW [29]. The weights were con-
structed using pooled logistic regression models for the proba-
bility of censoring on each day, in this case acquiring bacteremia 
[11]. Confounding was removed by reweighting patients in the 
risk set (those who were still present in the hospital and not ar-
tificially censored because of bacteremia) on each day [11, 19].
KM methodology with IPW was subsequently applied to the 
data. Subsequently, the survival probabilities for each day up 
to day t = 45 were summed to obtain the average LOS in the 
 absence of bacteremia.
The difference between the average observed LOS and the av-
erage LOS that would be observed if all bacteremias could be 
prevented was multiplied by the number of admitted patients, 
to obtain the total excess LOS attributable to ICU-acquired 
bacteremias. We estimated 95% confidence intervals (CIs) as 
described in Supplementary Material 2.
The effect per infection can be obtained by dividing the dif-
ference between the average observed LOS and the counterfac-
tual average LOS in the absence of infection by the probability 
of acquiring an infection during the ICU stay. All analyses 
were performed using R version 3.5.1 software (R code in 
Supplementary Material 3).
RESULTS
In total 2914 patients were admitted to the ICU and stayed > 
2 days in the ICU, contributing to 3157 ICU admissions. Table 1 
shows the characteristics of included admissions. Most patients 
had a relatively short total LOS (median, 7  days [25th–75th 
percentile, 4–15]), resulting in a highly skewed distribution 
(Figure  1, left panel). As mentioned earlier, patients were 
only included if they stayed > 2 days in the ICU; however, the 
first 2 days were added to the average LOS. The observed av-
erage LOS in the ICU was 11.44 (95% CI, 11.07–11.81) days 
when restricting the follow-up to the first 45  days after ad-
mission. There were 666 blood cultures positive for bacteria, 
with coagulase-negative staphylococci (44%), mixed bacteria 
(17%), Staphylococcus aureus (8%), Pseudomonas aeruginosa 
(6%), and Escherichia coli (4%) being the most commonly 
isolated bacteria. The majority (82%) of the 666 ICU-acquired 
bacteremias occurred within the first 2 weeks after admission 
(Figure 1, middle panel). However, among those still at risk of 
acquiring a bacteremia, the daily probability of acquiring it in-
itially increased over time (Figure 1, right panel). The width of 
the CIs around these probabilities increased over time due to 
the decreasing number of patients still at risk, precluding con-
clusions about the risk of bacteremia for long-stay patients.
Inverse Probability–Weighted Survival Curves
Details of the pooled logistic models used to create the in-
verse probability weights are provided in the Supplementary 
Material. The weights had a median and mean of 1.00 and 1.01, 
respectively, and an interquartile range and standard deviation 
of 0.06 and 0.13 (range, 0.44– 2.09), respectively. The values 
raise no concern that our results may be affected by extreme 
weights [29].
If all 666 ICU-acquired bacteremias would be prevented, the 
inverse probability–weighted KM curve predicted that patients 
would stay on average 10.66 (95% CI, 10.27–11.06) days when 
restricting the follow-up to the first 45 days after admission. The 
estimated total number of extra days in the ICU due to bacte-
remia were estimated at 2453 (95% CI, 1803–3103) days. The 
estimated number of excess days per infection were 3.7  days 
(11.439− 10.662) ∗ ( 6663157)−1.
Influence of Confounding
When ignoring confounding, using a weight of 1 for each ob-
servation, the number of excess days was estimated to be higher 
during the study period at 2838 (95% CI, 2101–3575) days. 
Similarly, the number of excess days was substantially overesti-
mated when taking only confounders measured at admission 
into account, with an estimated number of 2845 (95% CI, 2276–
3415) days attributable to infection.
Table 1. Characteristics of Patients for Intensive Care Unit Admissions of 
> 2 Days During the First 3–45 Days After Admission
Characteristic Admissions (N = 3157)a
Male sex, No. (%) 1915 (61)
Age, y, median (25th–75th percentile) 64 (50–74)
APACHE score at admission, median 
(25th–75th percentile)
18 (14–22)
Central lines at admission, No. (%) 2182 (69)
No. of antibiotics at admission, median 
(25th–75th percentile)
0 (0–2)
Mechanical ventilation at admission, 
No. (%)
2376 (75)
Died in ICU, No. (%) 626 (20)
Abbreviations: APACHE, Acute Physiology and Chronic Health Evaluation; ICU, intensive 
care unit.
aGiven that patients with an ICU stay < 3 days were excluded, the percentage of patients 
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DISCUSSION
In this article, we illustrated how to estimate the excess LOS as-
sociated with time-dependent exposures, such as ICU-acquired 
bacteremia, in the presence of time-varying confounding. The 
number of excess days due to ICU-acquired bacteremia was 
substantially overestimated when ignoring time-varying con-
founding, suggesting that future studies should adopt the meth-
odology presented here or alternative techniques [22, 23] that 
correctly address time-varying confounding without inducing 
collider-stratification bias or removing the indirect effects of 
early infection on the LOS that are mediated through the con-
sidered confounders.
Inverse probability–weighted KM methodology has ap-
pealing features compared to other techniques used in the lit-
erature. This includes the ability to simultaneously address the 
time-dependent nature of healthcare-acquired infections and 
time-invariant and time-varying confounding, as well as pro-
ducing excess LOS estimates measured in days. Moreover, in 
contrast to many other approaches, no (semi-)parametric as-
sumptions are needed on the distribution of LOS. The time-
dependent nature of ICU-acquired bacteremia was taken into 
account using IPW based on the daily probability of acquiring 
bacteremia among those still at risk. Other studies have ad-
dressed the time-dependent nature of nosocomial infections 
using multistate models, without accounting for time-varying 
confounding [1–3]. Given that one would expect that patients 
who acquire a bacteremia may be more severely ill and have de-
teriorated more than patients who remain infection-free, these 
previous studies have likely resulted in confounded estimates, 
thereby potentially overestimating the effect on excess LOS. 
While there are some recent studies that used g-methods such 
as IPW to address time-varying confounding to assess the effect 
of infections on ICU mortality and ICU discharge [11, 18, 26, 
30, 31], to our knowledge this is the first study that uses similar 
methodology to estimate the effect of time-varying exposures 
on excess LOS.
While we focused on ICU-acquired bacteremia, the meth-
odology proposed here can be applied to address any research 
question on the attributable effect of a (dichotomous) time-
varying exposure on an uncensored event time. Whenever di-
sease severity influences the decision to initiate drug therapy, 
time-varying confounding is likely [20]. If such confounding is 
influenced by prior exposure, thus also being an intermediate 
on the causal pathway, conventional regression approaches will 
Figure 1. Distributions of total length of intensive care unit stay (left), day of bacteremia onset (middle), and the probability of acquiring bacteremia on each day (right). The 
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provide biased estimates by removing part of the effect of the 
exposure and introducing selection bias. If there are competing 
events or other forms of censoring, our methodology can still be 
used if censoring is more broadly defined by treating both the 
exposure of interest and competing risks as censoring events, 
provided that there is no unmeasured confounding.
Our results add to the growing literature showing that ignoring 
confounding or only adjusting for confounders measured at 
baseline could result in substantial bias [11, 19, 20, 26, 30, 31]. In 
any case, evaluating whether (time-varying) confounding might 
play a role is preferable over directly applying multistate or other 
models without such adjustment, as such approaches implicitly 
assume that time-varying confounding can be ignored.
There are several limitations to our study. Regarding our case 
study, the estimates of the total excess number of ICU days due 
to ICU-acquired bacteremia rely on accurate measurements 
of all relevant confounders. We did not have information on 
some potential time-varying confounders such as surgeries 
or abdominal perforation and baseline confounders such as 
main reason for admission, which may both increase the risk 
of infection as well as the risk of death independent of infec-
tion. Therefore, we may have overestimated the effect of ICU-
acquired bacteremia and underestimated the impact of not 
accounting for all time-varying confounders, thereby further 
strengthening the case for collection and correct adjustment 
for time-varying confounders in future studies. When creating 
the pooled logistic regression models that are used for estima-
tion of the weights, it is important to consider potential relevant 
interactions and cumulative measures of daily measurements as 
these typically capture the evolution of severity of illness better 
than simple daily measurements alone.
The causal inference literature highlights that exchangeability 
(implying no unmeasured confounding, discussed above), pos-
itivity (the probability of acquiring bacteremia or remaining 
bacteremia-free being positive for every individual), and con-
sistency (informally the need for a well-defined [hypothetical] 
intervention) are necessary conditions for causal inference [30]. 
The mean of our estimated weights was 1.00 and there were no 
extreme values, thereby raising no concern about violation of 
the positivity assumption [29]. The need for a well-defined in-
tervention (consistency assumption) has been highly debated 
in the literature [32–34], with common misconceptions being 
that the hypothetical intervention needs to be currently fea-
sible, or that the net effect of the exposure of interest cannot 
be estimated if there is not a single well-defined (hypothetical) 
intervention that could be used to alter the exposure [33, 34]. 
Specifically for our study, the results can be viewed as providing 
an estimate of the harmful net effect of ICU-acquired bacte-
remia. This effect likely differs from the effect of an intervention 
to prevent ICU-acquired bacteremia because it is unlikely that 
such intervention would just prevent the development of bacte-
remia without having any other effects [33].
Onset of infection was defined using the time the first posi-
tive specimen was taken; however, it is uncertain whether onset 
may have occurred earlier. We used lagged values measured 
from the previous day to predict infection (and 2 days for the 
APACHE score and antibiotic treatment) to prevent adjustment 
for postinfection measurements.
Some positive blood cultures may have actually been contam-
inated blood samples (eg, some of those positive for coagulase-
negative staphylococci), thereby potentially leading to an 
underestimation of the effect of true bacteremia. Of note, this 
dataset was from before widespread implementation of infec-
tion control bundles for vascular catheter care, when coagulase-
negative staphylococci infections were more frequent and 
significant than now. The proportion of bacterial infections that 
are resistant to commonly used antibiotics has increased since 
the end of the study period and antibiotic resistance has been 
associated with increases in LOS [2, 3]. While these studies 
estimating the effect of resistance on LOS did not adjust for 
(time-varying) confounding, the current effect of ICU-acquired 
bacteremia may be larger than the estimate from this study.
We focused on bacteremias in general, which is a combina-
tion of all different types of bacteria with different antibiotic 
resistance profiles causing bacteremia. The effect of specific 
bacteria and associated resistances could be estimated in larger 
multicenter studies using similar methodology.
Finally, we could obtain the average effect per infection using 
the IPW KM methodology. However, this approach does not 
provide the excess LOS due to acquisition of an infection on a 
given day after admission, which is potentially easier to inter-
pret given the likely varying effects of acquisition of infections 
early after admission or much later during the ICU stay.
In summary, ICU-acquired bacteremia is associated with 
a substantial number of excess days in the ICU, even after 
adjusting for time-varying confounding. Inverse probability–
weighted KM curves form a relatively simple method to  estimate 
the causal effect of time-varying exposures on excess length of 
hospital stay. Wider adoption of this, or other techniques that 
correctly address time-varying confounding, could lead to 
better-informed decision making.
Supplementary Data
Supplementary materials are available at Clinical Infectious Diseases online. 
Consisting of data provided by the authors to benefit the reader, the posted 
materials are not copyedited and are the sole responsibility of the authors, 
so questions or comments should be addressed to the corresponding author.
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